ProfileGDS4718 / 207334_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 42% 36% 36% 41% 31% 35% 43% 43% 26% 35% 35% 31% 34% 40% 45% 28% 35% 38% 39% 32% 50% 35% 32% 37% 29% 41% 32% 32% 34% 38% 37% 35% 40% 41% 41% 30% 37% 38% 39% 40% 36% 38% 32% 39% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.0746842
GSM549102patient 115, normal, homogenized [OPG study]4.8334636
GSM549104patient 119, normal, homogenized [OPG study]4.7890336
GSM549108patient 138, normal, homogenized [OPG study]5.1151641
GSM549119patient 077, normal, homogenized [OPG study]4.5944631
GSM549133patient 032, cancer, homogenized [OPG study]4.6825835
GSM549139patient 042, cancer, homogenized [OPG study]5.0986943
GSM549099patient 107, normal, homogenized [OPG study]5.1574243
GSM549109patient 139, normal, homogenized [OPG study]4.4012726
GSM549110patient 046, normal, homogenized [OPG study]4.7564935
GSM549114patient 063, normal, homogenized [OPG study]4.7263935
GSM549122patient 082, normal, homogenized [OPG study]4.5836431
GSM549134patient 033, cancer, homogenized [OPG study]4.7061334
GSM549136patient 036, cancer, homogenized [OPG study]4.9319340
GSM549140patient 044, cancer, homogenized [OPG study]5.2054845
GSM549111patient 047, normal, homogenized [OPG study]4.4249328
GSM549113patient 057, normal, homogenized [OPG study]4.707235
GSM549132patient 031, cancer, homogenized [OPG study]4.8799938
GSM549137patient 038, cancer, homogenized [OPG study]4.910139
GSM549142patient 047, cancer, homogenized [OPG study]4.7395432
GSM549100patient 110, normal, homogenized [OPG study]5.4995850
GSM549107patient 135, normal, homogenized [OPG study]4.7261135
GSM549115patient 068, normal, homogenized [OPG study]4.5733732
GSM549116patient 072, normal, homogenized [OPG study]4.8118937
GSM549120patient 078, normal, homogenized [OPG study]4.4995429
GSM549131patient 030, cancer, homogenized [OPG study]4.9713441
GSM549118patient 074, normal, homogenized [OPG study]4.6369432
GSM549129patient 027, cancer, homogenized [OPG study]4.6502332
GSM549123patient 088, normal, homogenized [OPG study]4.6802634
GSM549124patient 006, cancer, homogenized [OPG study]4.9301838
GSM549126patient 015, cancer, homogenized [OPG study]4.8425237
GSM549128patient 025, cancer, homogenized [OPG study]4.7260335
GSM549103patient 117, normal, homogenized [OPG study]5.0385440
GSM549117patient 073, normal, homogenized [OPG study]4.9880541
GSM549138patient 041, cancer, homogenized [OPG study]5.0348241
GSM549141patient 045, cancer, homogenized [OPG study]4.4836830
GSM549130patient 028, cancer, homogenized [OPG study]4.8561537
GSM549101patient 111, normal, homogenized [OPG study]4.9339538
GSM549105patient 128, normal, homogenized [OPG study]4.9618539
GSM549106patient 134, normal, homogenized [OPG study]4.9334340
GSM549112patient 048, normal, homogenized [OPG study]4.811836
GSM549125patient 011, cancer, homogenized [OPG study]4.8859738
GSM549127patient 024, cancer, homogenized [OPG study]4.6075932
GSM549135patient 035, cancer, homogenized [OPG study]4.8960239